Advertisement

Antithrombotic Guidelines

  • Thomas DeLoughery
Chapter

Abstract

Patients receiving stem cell transplantation with specialized needs regarding antithrombotic therapy can fall into two basic groups: those who are on pre-transplant therapy and those who develop thrombosis during the course of the procedure. See Table 11.1 for a summary of management guidelines.

Keywords

Atrial Fibrillation Antiplatelet Therapy Antithrombotic Therapy Inferior Vena Cava Filter CHADS2 Score 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. ACCP Guidelines. (2008, Jun). Antithrombotic and thrombolytic therapy, 8th ed. Chest 133(Suppl), 67S–968S.Google Scholar
  2. Grines, C.L., Bonow, R.O., Casey, D.E. Jr, Gardner, T.J., Lockhart, P.B., Moliterno, D.J., et al. (2007). Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation, 115:813–818.Google Scholar
  3. Jones, M.A., Lee, D.Y., Segall, J.A., Landry, G.J., Liem, T.K., Mitchell, E.L., et al. (2010). Characterizing resolution of catheter-associated upper extremity deep venous thrombosis. J Vasc Surg, 51:108–113.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Thomas DeLoughery
    • 1
  1. 1.Divisions of Hematology/Oncology and Laboratory MedicineOregon Health and Science UniversityPortlandUSA

Personalised recommendations